
COGVIO, an IQVIA business, is a technology and data science company founded in 2017, specializing in digital tools for the pharmaceutical and healthcare industries. Their core product, Price Monitor, is an AI-powered system that integrates over 100 global data sources to provide market access and pricing insights. It assists clients with drug launches, strategic decisions, and price management throughout a product's lifecycle, offering competitor intelligence, international reference pricing analysis, and price erosion control. COGVIO also offers custom data analysis projects and healthcare software development, ensuring compliance with regulations like GDPR, GAMP, and HIPAA. They aim to streamline IT innovations in healthcare, with solutions used by market access and pricing teams globally for data-driven decision-making.

COGVIO, an IQVIA business, is a technology and data science company founded in 2017, specializing in digital tools for the pharmaceutical and healthcare industries. Their core product, Price Monitor, is an AI-powered system that integrates over 100 global data sources to provide market access and pricing insights. It assists clients with drug launches, strategic decisions, and price management throughout a product's lifecycle, offering competitor intelligence, international reference pricing analysis, and price erosion control. COGVIO also offers custom data analysis projects and healthcare software development, ensuring compliance with regulations like GDPR, GAMP, and HIPAA. They aim to streamline IT innovations in healthcare, with solutions used by market access and pricing teams globally for data-driven decision-making.
Founded: 2017
Headquarters: Prague, Czech Republic
Core product: Price Monitor (AI-powered pricing & market-access platform)
Acquisition status: Acquired by IQVIA (operates as an IQVIA business)
Drug pricing, market access, reimbursement intelligence and healthcare data analysis for pharmaceutical clients.
2017
Healthcare / Pharmaceutical software
Public profiles record a Series A in November 2020; amount not publicly disclosed.